Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review

DeSantis, 2015, International Variation in Female Breast Cancer Incidence and Mortality Rates, Cancer Epidemiol. Biomarkers Prev., 24, 1495, 10.1158/1055-9965.EPI-15-0535

The Global Cancer Observatory, and International Agent for Research on Cancer (2021, October 13). Breast. Available online: https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf.

Waks, 2019, Breast Cancer Treatment: A Review, JAMA, 321, 288, 10.1001/jama.2018.19323

Wojtyla, C., Bertuccio, P., Ciebiera, M., and La Vecchia, C. (2021). Breast Cancer Mortality in the Americas and Australasia over the Period 1980–2017 with Predictions for 2025. Biology, 10.

Glassman, 2017, Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update, Anticancer Res., 37, 5329

Pan, 2017, 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years, N. Engl. J. Med., 377, 1836, 10.1056/NEJMoa1701830

Pagani, 2014, Adjuvant exemestane with ovarian suppression in premenopausal breast cancer, N. Engl. J. Med., 371, 107, 10.1056/NEJMoa1404037

Francis, 2018, Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer, N. Engl. J. Med., 379, 122, 10.1056/NEJMoa1803164

Ciruelos, 2019, Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer, N. Engl. J. Med., 380, 1929, 10.1056/NEJMoa1813904

Baselga, 2012, Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer, N. Engl. J. Med., 366, 520, 10.1056/NEJMoa1109653

Im, 2019, Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer, N. Engl. J. Med., 381, 307, 10.1056/NEJMoa1903765

Turner, 2018, Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer, N. Engl. J. Med., 379, 1926, 10.1056/NEJMoa1810527

Hortobagyi, 2021, LBA17_PR—Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB), Ann. Oncol., 32, S1283, 10.1016/j.annonc.2021.08.2090

Buchanan, 2015, Post-treatment Neurocognition and Psychosocial Care Among Breast Cancer Survivors, Am. J. Prev. Med., 49, S498, 10.1016/j.amepre.2015.08.013

Bluethmann, 2017, Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study, Oncol. Nurs. Forum, 44, E101, 10.1188/17.ONF.E101-E110

Boele, 2015, Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer, Menopause, 22, 17, 10.1097/GME.0000000000000271

Buwalda, 2013, Is basic research providing answers if adjuvant anti-estrogen treatment of breast cancer can induce cognitive impairment?, Life Sci., 93, 581, 10.1016/j.lfs.2012.12.012

MacLusky, 1986, Estrogen formation and binding in the cerebral cortex of the developing rhesus monkey, Proc. Natl. Acad. Sci. USA, 83, 513, 10.1073/pnas.83.2.513

Biro, 2019, Cognitive Functioning and Psychological Well-being in Breast Cancer Patients on Endocrine Therapy, In Vivo, 33, 1381, 10.21873/invivo.11615

Nalvarte, 2021, Estrogen receptor beta and neural development, Vitam. Horm., 116, 313, 10.1016/bs.vh.2021.02.007

2008, Aromatase in the brain: Not just for reproduction anymore, J. Neuroendocrinol., 20, 705, 10.1111/j.1365-2826.2008.01713.x

Bian, 2014, Aromatase inhibitor letrozole downregulates steroid receptor coactivator-1 in specific brain regions that primarily related to memory, neuroendocrine and integration, J. Steroid. Biochem. Mol. Biol., 141, 37, 10.1016/j.jsbmb.2013.12.020

Kretz, 2004, Hippocampal synapses depend on hippocampal estrogen synthesis, J. Neurosci., 24, 5913, 10.1523/JNEUROSCI.5186-03.2004

Daniel, 1999, Effects of ovarian hormones and environment on radial maze and water maze performance of female rats, Physiol. Behav., 66, 11, 10.1016/S0031-9384(98)00272-8

Luine, 1998, Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters, Horm. Behav., 34, 149, 10.1006/hbeh.1998.1473

Bimonte, 1999, Estradiol facilitates performance as working memory load increases, Psychoneuroendocrinology, 24, 161, 10.1016/S0306-4530(98)00068-7

Zec, 2002, The effects of estrogen replacement therapy on neuropsychological functioning in postmenopausal women with and without dementia: A critical and theoretical review, Neuropsychol. Rev., 12, 65, 10.1023/A:1016880127635

Schacter, 1999, Medial temporal lobe activations in fMRI and PET studies of episodic encoding and retrieval, Hippocampus, 9, 7, 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K

Maki, 2009, Hormone therapy and cognitive function, Hum. Reprod. Update, 15, 667, 10.1093/humupd/dmp022

Eberling, 2004, Estrogen- and tamoxifen-associated effects on brain structure and function, Neuroimage, 21, 364, 10.1016/j.neuroimage.2003.08.037

Hurria, 2014, The effect of aromatase inhibition on the cognitive function of older patients with breast cancer, Clin. Breast Cancer, 14, 132, 10.1016/j.clbc.2013.10.010

Joffe, 2006, Estrogen therapy selectively enhances prefrontal cognitive processes: A randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women, Menopause, 13, 411, 10.1097/01.gme.0000189618.48774.7b

Harvey, 2012, Clinical applications of neuropsychological assessment, Dialogues Clin. Neurosci., 14, 91, 10.31887/DCNS.2012.14.1/pharvey

Schilder, 2012, Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: Findings from the neuropsychological TEAM side-study, Psychooncology, 21, 479, 10.1002/pon.1928

Wagner, 2009, Measuring patient self-reported cognitive function: Development of the Functional Assessment of Cancer Therapy–Cognitive Function Instrument, J. Support Oncol., 7, W32

Broadbent, 1982, The Cognitive Failures Questionnaire (CFQ) and its correlates, Br. J. Clin. Psychol., 21, 1, 10.1111/j.2044-8260.1982.tb01421.x

Aaronson, 1993, The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology, J. Natl. Cancer Inst., 85, 365, 10.1093/jnci/85.5.365

Delbeuck, 2015, A phase III randomized multicenter trial evaluating cognition in post-menopausal breast cancer patients receiving adjuvant hormonotherapy, Breast Cancer Res. Treat., 152, 569, 10.1007/s10549-015-3493-1

Danhauer, 2013, Positive and negative affect, depression, and cognitive processes in the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Trial, Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn., 20, 532, 10.1080/13825585.2012.747671

Jenkins, 2008, Effects of anastrozole on cognitive performance in postmenopausal women: A randomised, double-blind chemoprevention trial (IBIS II), Lancet Oncol., 9, 953, 10.1016/S1470-2045(08)70207-9

Legault, 2009, Effects of tamoxifen and raloxifene on memory and other cognitive abilities: Cognition in the study of tamoxifen and raloxifene, J. Clin. Oncol., 27, 5144, 10.1200/JCO.2008.21.0716

Berndt, 2016, Memory and Spatial Cognition in Breast Cancer Patients Undergoing Adjuvant Endocrine Therapy, Breast Care, 11, 240, 10.1159/000446901

Hedayati, 2012, Effects of adjuvant treatment on cognitive function in women with early breast cancer, Eur. J. Oncol. Nurs., 16, 315, 10.1016/j.ejon.2011.07.006

Mandelblatt, 2018, Cancer-Related Cognitive Outcomes Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study, J. Clin. Oncol., 36, Jco1800140, 10.1200/JCO.18.00140

Collins, 2009, Cognitive effects of hormonal therapy in early stage breast cancer patients: A prospective study, Psychooncology, 18, 811, 10.1002/pon.1453

Chen, 2014, Decision-making impairments in breast cancer patients treated with tamoxifen, Horm. Behav., 66, 449, 10.1016/j.yhbeh.2014.07.005

Palmer, 2008, Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls, J. Cancer Surviv., 2, 275, 10.1007/s11764-008-0070-1

Shilling, 2003, The effects of hormone therapy on cognition in breast cancer, J. Steroid Biochem. Mol. Biol., 86, 405, 10.1016/j.jsbmb.2003.07.001

Schilder, 2010, Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: Results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial, J. Clin. Oncol., 28, 1294, 10.1200/JCO.2008.21.3553

Underwood, 2019, Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: A 1-year longitudinal study, Support Care Cancer, 27, 3035, 10.1007/s00520-018-4603-5

Lejbak, 2010, Endocrine therapy is associated with low performance on some estrogen-sensitive cognitive tasks in postmenopausal women with breast cancer, J. Clin. Exp. Neuropsychol., 32, 836, 10.1080/13803391003596389

Ganz, 2016, Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): A randomised, double-blind, phase 3 clinical trial, Lancet, 387, 857, 10.1016/S0140-6736(15)01169-1

Bender, 2015, Patterns of change in cognitive function with anastrozole therapy, Cancer, 121, 2627, 10.1002/cncr.29393

Chen, 2017, Impairment of the executive attention network in premenopausal women with hormone receptor-positive breast cancer treated with tamoxifen, Psychoneuroendocrinology, 75, 116, 10.1016/j.psyneuen.2016.10.020

Chen, 2017, The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen, Int. J. Neuropsychopharmacol., 20, 374, 10.1093/ijnp/pyx008

Harbeck, 2016, Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor-positive, HER2-negative metastatic breast cancer: Patient-reported outcomes from the PALOMA-3 trial, Ann. Oncol., 27, 1047, 10.1093/annonc/mdw139

Kahan, 2021, Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study, Eur. J. Cancer, 156, 70, 10.1016/j.ejca.2021.07.004

Kaufman, 2020, Health-Related Quality of Life in MONARCH 2: Abemaciclib plus Fulvestrant in Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer After Endocrine Therapy, Oncologist, 25, e243, 10.1634/theoncologist.2019-0551

Mandelblatt, 2020, Symptom burden among older breast cancer survivors: The Thinking and Living with Cancer (TLC) study, Cancer, 126, 1183, 10.1002/cncr.32663

Merriman, 2017, Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer, Psychooncology, 26, 44, 10.1002/pon.4009

Morales, 2004, Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients, Anticancer Drugs, 15, 753, 10.1097/00001813-200409000-00003

Wagner, 2020, Patient-Reported Cognitive Impairment Among Women with Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx, J. Clin. Oncol., 38, 1875, 10.1200/JCO.19.01866

Bender, 2018, Trajectories of Cognitive Function and Associated Phenotypic and Genotypic Factors in Breast Cancer, Oncol. Nurs. Forum, 45, 308, 10.1188/18.ONF.308-326

Bender, 2007, Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer, Menopause, 14, 995, 10.1097/gme.0b013e318148b28b

Tometich, 2019, Pretreatment Psychoneurological Symptoms and Their Association With Longitudinal Cognitive Function and Quality of Life in Older Breast Cancer Survivors, J. Pain Symptom Manag., 57, 596, 10.1016/j.jpainsymman.2018.11.015

Liu, 2013, Apolipoprotein E and Alzheimer disease: Risk, mechanisms and therapy, Nat. Rev. Neurol., 9, 106, 10.1038/nrneurol.2012.263

Koleck, 2014, Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer, Oncol. Nurs. Forum, 41, E313, 10.1188/14.ONF.E313-E325

Li, 2016, Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?, Mol. Neurobiol., 53, 4238, 10.1007/s12035-015-9341-9

Campbell, 2020, The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials, Phys. Ther., 100, 523, 10.1093/ptj/pzz090

Rogers, 2009, Physical activity and health outcomes three months after completing a physical activity behavior change intervention: Persistent and delayed effects, Cancer Epidemiol. Biomarkers Prev., 18, 1410, 10.1158/1055-9965.EPI-08-1045

Hartman, 2018, Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study, Cancer, 124, 192, 10.1002/cncr.30987

Fernandes, 2019, Cognitive rehabilitation for cancer-related cognitive dysfunction: A systematic review, Support Care Cancer, 27, 3253, 10.1007/s00520-019-04866-2

Myers, 2020, Emerging From the Haze: A Multicenter, Controlled Pilot Study of a Multidimensional, Psychoeducation-Based Cognitive Rehabilitation Intervention for Breast Cancer Survivors Delivered With Telehealth Conferencing, Arch. Phys. Med. Rehabil., 101, 948, 10.1016/j.apmr.2020.01.021

Hosseini, 2020, The Effect of CoQ(10) Supplementation on Quality of Life in Women with Breast Cancer Undergoing Tamoxifen Therapy: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial, Psychol. Res. Behav. Manag., 13, 151, 10.2147/PRBM.S241431

Lyons, L., Elbeltagy, M., Bennett, G., and Wigmore, P. (2012). Fluoxetine Counteracts the Cognitive and Cellular Effects of 5-Fluorouracil in the Rat Hippocampus by a Mechanism of Prevention Rather than Recovery. PLoS ONE, 7.

Lim, 2016, PET Evidence of the Effect of Donepezil on Cognitive Performance in an Animal Model of Chemobrain, Biomed Res. Int., 2016, 6945415, 10.1155/2016/6945415

Iarkov, 2016, Post-treatment with cotinine improved memory and decreased depressive-like behavior after chemotherapy in rats, Cancer Chemother. Pharmacol., 78, 1033, 10.1007/s00280-016-3161-0

Vukelja, 2005, Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy, Clin. Breast Cancer, 5, 439, 10.3816/CBC.2005.n.002

Park, 2009, The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer, Psycho-Oncology, 18, 156, 10.1002/pon.1372

Lawrence, 2016, A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy, J. Cancer Surviv., 10, 176, 10.1007/s11764-015-0463-x

Mohile, 2009, Neuroprotective effect of SSRI among 781 cancer patients receiving chemotherapy: A URCC CCOP Study, J. Clin. Oncol., 27, 9512, 10.1200/jco.2009.27.15_suppl.9512

Kohli, 2009, The effect of modafinil on cognitive function in breast cancer survivors, Cancer, 115, 2605, 10.1002/cncr.24287

Lundorff, 2009, Modafinil for attentional and psychomotor dysfunction in advanced cancer: A double-blind, randomised, cross-over trial, Palliat. Med., 23, 731, 10.1177/0269216309106872

Escalante, 2014, A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients, Cancer J., 20, 8, 10.1097/PPO.0000000000000018

Lower, 2009, Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial, J. Pain Symptom Manag., 38, 650, 10.1016/j.jpainsymman.2009.03.011

Clemons, 2008, A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer, Support Care Cancer, 16, 577, 10.1007/s00520-007-0341-9

Berenson, 2015, A phase 3 trial of armodafinil for the treatment of cancer-related fatigue for patients with multiple myeloma, Support Care Cancer, 23, 1503, 10.1007/s00520-014-2486-7

Chen, 2013, MEK1/2 inhibition suppresses tamoxifen toxicity on CNS glial progenitor cells, J. Neurosci., 33, 15069, 10.1523/JNEUROSCI.2729-13.2013

Wefel, 2011, International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer, Lancet Oncol., 12, 703, 10.1016/S1470-2045(10)70294-1